期刊文献+

新诊断2型糖尿病胰岛素分泌和胰岛素抵抗特点的研究 被引量:1

Research of the characteristics of insulin secretion and insulin resistance in new diagnosed type 2 diabetes
下载PDF
导出
摘要 目的:探讨新诊断2型糖尿病胰岛素分泌和胰岛素抵抗特点。方法:收治新诊断2型糖尿病患者70例作为试验组,选取同期健康人群70例作为对照组,比较两组胰岛素抵抗指数(HOMA-IR)、β细胞功能指数(HOMA-IS)与胰岛素敏感性指数(ISI)。结果:试验组胰岛素抵抗指数明显高于对照组,β细胞功能指数与胰岛素敏感性指数均低于对照组,差异有统计学意义(P<0.05)。结论:新诊断2型糖尿病患者的胰岛素分泌和胰岛素抵抗功能显著下降。 Objective:To investigate the characteristics of insulin secretion and insulin resistance in new diagnosed type 2 diabetes.Methods:70 cases of patients with new diagnosed type 2 diabetes were selected as the experiment group.70 cases of healthy people in the same period were selected as the control group.The insulin resistance index (HOMA-IR),the beta cell function index (HOMA-IS) and the insulin sensitivity- index (ISI) between groups were compared.Results:The insulin resistance index of the experiment group was significantly higher than that of the control group,and the beta cell function index and the insulin sensitivity index were all lower than those of the control group,and the difference was statistically- significant (P 〈 0.05). Conclusion:The insulin secretion and insulin resistance of the new diagnosed type 2 diabetic patients decreased significantly.
作者 何小琼 He Xiaoqiong(The Traditional Chinese Medicine Hospital of Fuling District Chongqing City 40800)
出处 《中国社区医师》 2018年第15期115-115,117,共2页 Chinese Community Doctors
关键词 新诊断 2型糖尿病 胰岛素分泌 胰岛素抵抗 New diagnosis Type 2 diabetes Insulin secretion Insulin resistance
  • 相关文献

参考文献4

二级参考文献20

  • 1杨媚,杨刚毅,李伶,李清明,阮华玲,阳皓,李钶,孙勤,唐毅,Gunther Boden.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. 被引量:76
  • 2宁洁,唐炜立,周智广,冯琼,刘玉华,周卫东.格列美脲与二甲双胍对2型糖尿病胰岛素抵抗的影响[J].中国现代医学杂志,2006,16(14):2224-2225. 被引量:5
  • 3柳迎昭,孙亦娟.格列美脲联合胰岛素治疗单用胰岛素控制血糖不佳的2型糖尿病疗效观察[J].中国医师进修杂志(内科版),2006,29(11):49-50. 被引量:6
  • 4MLLER G,SATOH Y,GEISEN K.Extrapancreaticeffects of sulfonylureas—a comparison between glimepiride and conventional sulfonylureas[J].Diabetes Res Clin Pract,1995,28Suppl:S115-S137.
  • 5DROUIN P.Diamicron MR once daily is effective and well tolerated in type2diabetes:a double-blind,randomized,multinational study[J].J Diabetes Complications,2000,14(4):185-191.
  • 6HATAO K,KAKU K,MATSUDA M,et al.Sulfonylurea stimulates liver fructose-2,6-bisphosphate formation in proportion to its hypoglycemic action[J].Diabetes Res Clin Pract,1985,1(1):49-53.
  • 7MORI R C,HIRABARA S M,HIRATA A E,et al.Glimepiride as insulin sensitizer:increased liver and muscle responses to insulin[J].Diabetes Obes Metab,2008,10(7):596-600.
  • 8OSE H,FUKUI M,KITAGAWA Y,et al.Efficacy of glimepiride in patients with poorly controlled insulin-treated type2diabetes mellitus[J].Endocr J,2005,52(5):563569.
  • 9KOBAYASHI M,KAKU K,KAWAMORI R,et al.Glimepiride improves HbA1c without weight gain in obese Japanese type2diabetic patients[J].Diabetes,2003,52(1):A97.
  • 10权启镇,孙自勤,王要军.新肝脏病学[M].济南:山东科学技术出版社,2008:948.

共引文献19

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部